Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis

Circulation: Cardiovascular Interventions

Volumn 8, Issue 1, 2015, Pages

  Schymik, Gerhard ^a   Würth, Alexander ^b   Bramlage, Peter ^c   Herbinger, Tanja ^a   Heimeshoff, Martin ^d   Pilz, Lothar ^e   Schymik, Jan S ^f   Wondraschek, Rainer ^a   Süselbeck, Tim ^g   Gerhardus, Jan ^b   Luik, Armin ^a   Gonska, Bernd Dieter ^b   Posival, Herbert ^d   Schmitt, Claus ^a   Schröfel, Holger ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b St Vincentius Hospital Karlsruhe   (Germany)

^c Institute für Pharmakologie und Präventive Medizin   (Germany)

^d Clinic for Cardiac Surgery Karlsruhe   (Germany)

^e MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Aortic valve replacement; Mortality; Transcatheter

Indexed keywords

CREATININE;

AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; EUROSCORE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POST TREATMENT SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; QUALITY OF LIFE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; ANATOMY AND HISTOLOGY; AORTIC VALVE INSUFFICIENCY; COMPARATIVE STUDY; FEMORAL ARTERY; HEART; HEART SURGERY; INTERDISCIPLINARY COMMUNICATION; MORTALITY; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; CARDIAC SURGICAL PROCEDURES; FEMALE; FEMORAL ARTERY; HEART; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84927767129     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.000761     Document Type: Article

References (39)

1. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698-703. doi: 10.1016/j.jacc.2003.11.026
2. Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Alegria Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L; Transcatheter Valve Treatment Sentinel Registry (TCVT) Investigators of the EURObservational Research Programme (EORP) of the European Society of Cardiology. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention. 2013;8:1362-1371. doi: 10.4244/EIJV8I12A209
3. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69. doi: 10.1161/CIRCULATIONAHA.109.907402
4. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197. doi: 10.1093/eurheartj/ehq261
5. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204. doi: 10.1093/eurheartj/ehq339
6. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123: 299-308. doi: 10.1161/CIRCULATIONAHA.110.946533
7. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, DeLarochellière R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864-1875. doi: 10.1016/j. jacc.2012.08.960
8. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425-433. doi: 10.1161/CIRCULATIONAHA.110.001545
9. van der Boon RM, Marcheix B, Tchetche D, Chieffo A, Van Mieghem NM, Dumonteil N, Vahdat O, Maisano F, Serruys PW, Kappetein AP, Fajadet J, Colombo A, Carrié D, van Domburg RT, de Jaegere PP. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study. Ann Thorac Surg. 2014;97:22-28. doi: 10.1016/j.athoracsur.2013.09.088
10. Blackman DJ, Baxter PD, Gale CP, Moat NE, Maccarthy PA, Hildick-Smith D, Trivedi U, Cunningham D, DE Belder MA, Ludman PF; National Institute for Cardiovascular Outcomes Research (NICOR). Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. J Interv Cardiol. 2014;27:86-95. doi: 10.1111/joic.12084
11. Johansson M, Nozohoor S, Kimblad PO, Harnek J, Olivecrona GK, Sjögren J. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety. Ann Thorac Surg. 2011;91:57-63. doi: 10.1016/j.athoracsur.2010.07.072
12. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28. doi: 10.1016/j. jacc.2010.07.036
13. Ewe SH, Delgado V, Ng AC, Antoni ML, van der Kley F, Marsan NA, de Weger A, Tavilla G, Holman ER, Schalij MJ, Bax JJ. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg. 2011;92:1244-1251. doi: 10.1016/j. athoracsur.2011.01.059
14. Szeto WY, Augoustides JG, Desai ND, Moeller P, McGarvey ML, Walsh E, Bannan A, Herrmann HC, Bavaria JE. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg. 2011;26:348-354. doi: 10.1111/j.1540-8191.2011.01265.x
15. Bleiziffer S, Ruge H, Mazzitelli D, Hutter A, Opitz A, Bauernschmitt R, Lange R. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg. 2009;138:1073-1080. doi: 10.1016/j.jtcvs.2009.07.031
16. Rodés-Cabau J, Dumont E, De LaRochellière R, Doyle D, Lemieux J, Bergeron S, Clavel MA, Villeneuve J, Raby K, Bertrand OF, Pibarot P. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol. 2008;102:1240-1246. doi: 10.1016/j.amjcard.2008.06.061
17. Schymik G, Schröfel H, Schymik JS, Wondraschek R, Süselbeck T, Kiefer R, Balthasar V, Luik A, Posival H, Schmitt C. Acute and late outcomes of Transcatheter Aortic Valve Implantation (TAVI) for the treatment of severe symptomatic aortic stenosis in patients at high-And low-surgical risk. J Interv Cardiol. 2012;25:364-374. doi: 10.1111/j.1540-8183.2012.00729.x
18. Schymik G, Heimeshoff M, Bramlage P, Wondraschek R, Süselbeck T, Gerhardus J, Luik A, Posival H, Schmitt C, Schröfel H. Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol. 2014;103:912-920. doi: 10.1007/s00392-014-0729-8
19. Schymik G, Tzamalis P, Bramlage P, Heimeshoff M, Würth A, Wondraschek R, Gonska B-D, Posival H, Schmitt C, Schröfel H, Luik A. Clinical impact of a new left bundle branch block following tavi implantation: one year results of the tavik cohort. Clin Res Cardiol. 2014:10.1007/s00392-00014-00791-00392
20. Afilalo J, Mottillo S, Eisenberg MJ, Alexander KP, Noiseux N, Perrault LP, Morin JF, Langlois Y, Ohayon SM, Monette J, Boivin JF, Shahian DM, Bergman H. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes. 2012;5:222-228. doi: 10.1161/CIRCOUTCOMES.111.963157
21. Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin. 2010;60:120-132. doi: 10.3322/caac.20059
22. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention. 2012;8:782-795. doi: 10.4244/EIJV8I7A121
23. Shadish WR, Steiner PM. A primer on propensity score analysis. Newborn Infant Nurs Rev. 2010;10:19-26
24. Rosenbaum P, Rubin D. Constructing a control group using multivariate matched sampling methods that incorporate the propenstiy score. Am Stat. 1985;3:33-38
25. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134:1128-1135. doi: 10.1016/j. jtcvs.2007.07.021
26. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090. doi: 10.1016/j.jacc.2009.12.014
27. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607. doi: 10.1056/NEJMoa1008232
28. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. doi: 10.1056/NEJMoa1103510
29. Holzhey DM, Hänsig M, Walther T, Seeburger J, Misfeld M, Linke A, Borger MA, Mohr FW. Transapical aortic valve implantation-The Leipzig experience. Ann Cardiothorac Surg. 2012;1:129-137. doi: 10.3978/j. issn.2225-319X.2012.06.09
30. Wendt D, Eggebrecht H, Kahlert P, Heine T, Kottenberg E, Massoudy P, Kamler M, Peters J, Erbel R, Jakob H, Thielmann M. [Experience and learning curve with transapical aortic valve implantation]. Herz. 2009;34:388-397. doi: 10.1007/s00059-009-3265-y
31. Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M. The SOURCE Registry: what is the learning curve in trans-Apical aortic valve implantation? Eur J Cardiothorac Surg. 2011;39:853-859, discussion 859. doi: 10.1016/j.ejcts.2010.11.018
32. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Mladenow A, D'Ancona G, Hetzer R, Seifert B. Introducing transapical aortic valve implantation (part 1): effect of a structured training program on clinical outcome in a series of 500 procedures. J Thorac Cardiovasc Surg. 2013;145:911-918. doi: 10.1016/j.jtcvs.2012.12.057
33. Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851-858. doi: 10.1016/j.jcin.2011.03.019
34. Khatri PJ, Webb JG, Rodés-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC, Ko DT. Adverse effects associated with transcatheter aortic valve implantation: a meta-Analysis of contemporary studies. Ann Intern Med. 2013;158:35-46. doi: 10.7326/0003-4819-158-1-201301010-00007
35. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv. 2009;2:811-820. doi: 10.1016/j. jcin.2009.07.005
36. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113: 842-850. doi: 10.1161/CIRCULATIONAHA.105.582882
37. Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2013;6:293-300. doi: 10.1016/j.jcin.2012.09.019
38. Aregger F, Wenaweser P, Hellige GJ, Kadner A, Carrel T, Windecker S, Frey FJ. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant. 2009;24:2175-2179. doi: 10.1093/ndt/gfp036
39. Saia F, Ciuca C, Taglieri N, Marrozzini C, Savini C, Bordoni B, Dall'Ara G, Moretti C, Pilato E, Martìn-Suàrez S, Petridis FD, Di Bartolomeo R, Branzi A, Marzocchi A. Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. Int J Cardiol. 2013;168:1034-1040. doi: 10.1016/j. ijcard.2012.10.029.